This page includes the latest FDA filings for Epizyme Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | EPZM | DUNS 018795119 |
Device Company | Device | Date |
|---|---|---|
| Epizyme, Inc., Patheon Pharmaceuticals Inc., Sterling Pharma Solutions Limited | Prescription Medication | 2024-08-20 |
| Epizyme, Inc., Patheon Pharmaceuticals Inc., Sterling Pharma Solutions Limited | Prescription Medication | 2023-12-27 |
| Epizyme, Inc., Patheon Pharmaceuticals Inc., Sterling Pharma Solutions Limited | Prescription Medication | 2023-11-23 |
| Epizyme, Inc., Patheon Pharmaceuticals Inc., Sterling Pharma Solutions Limited | Prescription Medication | 2023-09-22 |
| Epizyme, Inc., Patheon Pharmaceuticals Inc., Sterling Pharma Solutions Limited | Prescription Medication | 2020-08-04 |
| Epizyme, Inc., Patheon Pharmaceuticals Inc., Sterling Pharma Solutions Limited | Prescription Medication | 2020-07-01 |
EPIZYME INC | 2020-06-23 19:23:53 | |
| Epizyme, Inc., Patheon Pharmaceuticals Inc., Sterling Pharma Solutions Limited | Prescription Medication | 2020-01-30 |
| Epizyme, Inc. | TAZVERIK | 2020-01-23 |
EPIZYME INC | 0000-00-00 00:00:00 |
| NCAGE Code | 61Q34 | EPIZYME, INC. |
| CAGE Code | 61Q34 | EPIZYME, INC. |
| SEC | 0001571498 | Epizyme, Inc. of DELAWARE |